genAI
Selected early versions will be slated for real-world deployment.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
HIMSS25
Kathy Bailey, principal data intelligence analyst at Cedars-Sinai Medical Center, discusses how she and her team used generative AI to identify pickleball injuries from patients' chart notes with 80% accuracy.
Developed using a corpus of 38 million clinical texts, the open-source model scored 86% in the Korean Medical Licensing Examination.
The EMR-linked tool has been implemented across 16 departments.
Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.
Project Stargate includes a partnership between Oracle's Larry Ellison, OpenAI's Sam Altman and SoftBank's Masayoshi Son that aims to enhance cancer detection and personalized vaccines.
A Singaporean startup is set to introduce its doctor companion AI across Australia and Southeast Asia starting this year.
HIMSS24
Ran Balicer, HIMSS board of directors member, talks about the possibility of clinical digital support technology to personalize care by helping clinicians predict potential health issues for patients so they can be prevented.
Cedars-Sinai CIO Craig Kwiatkowski discusses using the FAVES approach (fair, appropriate, valid, effective and safe) in genAI adoption, as well as the "build vs buy" question, and challenges with integrating AI technologies into existing systems.